These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6455095)

  • 41. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris.
    Leyden JJ; Krochmal L; Yaroshinsky A
    J Am Acad Dermatol; 2006 Jan; 54(1):73-81. PubMed ID: 16384759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
    Gold MH; Rao J; Goldman MP; Bridges TM; Bradshaw VL; Boring MM; Guider AN
    J Drugs Dermatol; 2005; 4(1):64-70. PubMed ID: 15696987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris.
    Sheehan-Dare RA; Papworth-Smith J; Cunliffe WJ
    Acta Derm Venereol; 1990; 70(6):534-7. PubMed ID: 1981436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of acne vulgaris with topical clindamycin phosphate: a double-blind study.
    Guin JD
    Int J Dermatol; 1981 May; 20(4):286-8. PubMed ID: 6453849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
    Cambazard F
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris.
    Leyden JJ; Shalita AR; Saatjian GD; Sefton J
    J Am Acad Dermatol; 1987 Apr; 16(4):822-7. PubMed ID: 2952685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial.
    Morganti P; Berardesca E; Guarneri B; Guarneri F; Fabrizi G; Palombo P; Palombo M
    Int J Cosmet Sci; 2011 Oct; 33(5):467-76. PubMed ID: 21668835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison.
    Shahlita AR; Smith EB; Bauer E
    Arch Dermatol; 1984 Mar; 120(3):351-5. PubMed ID: 6230999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical use of tetracycline in the treatment of acne: a double-blind study comparing topical and oral tetracycline therapy and placebo.
    Blaney DJ; Cook CH
    Arch Dermatol; 1976 Jul; 112(7):971-3. PubMed ID: 132901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of clindamycin 1% solution versus clindamycin 1% gel in the treatment of acne vulgaris.
    Parker F
    Int J Dermatol; 1987 Mar; 26(2):121-2. PubMed ID: 2952611
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical evaluation of a topical ethyl lactate treatment of acne vulgaris (author's transl)].
    Grosshans E; Fourtanier A; Guibaud B
    Ann Dermatol Venereol; 1978 Oct; 105(10):833-8. PubMed ID: 154872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
    Puhvel SM
    Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris.
    Babayeva L; Akarsu S; Fetil E; Güneş AT
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):328-33. PubMed ID: 20666879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topical clindamycin treatment of acne. Clinical, surface lipid composition, and quantitative surface microbiology response.
    Thomsen RJ; Stranieri A; Knutson D; Strauss JS
    Arch Dermatol; 1980 Sep; 116(9):1031-4. PubMed ID: 6448025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.
    Shalita AR; Smith JG; Parish LC; Sofman MS; Chalker DK
    Int J Dermatol; 1995 Jun; 34(6):434-7. PubMed ID: 7657446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
    Schachner L; Pestana A; Kittles C
    J Am Acad Dermatol; 1990 Mar; 22(3):489-95. PubMed ID: 2138180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne.
    Cunliffe WJ; Fernandez C; Bojar R; Kanis R; West F;
    J Dermatolog Treat; 2005; 16(4):213-8. PubMed ID: 16302325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.